Drugmakers to face drug price cuts

Domestic and foreign manufacturers of antihypertensive agents is set to face an imminent drug pricing reform with price cut proposals already put forward to the presidential Blue House by the Ministry for Health, Welfare and Family Affairs.

So far, the details of the reform proposal have not been officially revealed, but speculations have started spreading that both innovative and generic an...